Cite
APA Citation
Nishio, M., Takahashi, T., Yoshioka, H., Nakagawa, K., Fukuhara, T., Yamada, K., Ichiki, M., Tanaka, H., Seto, T., Sakai, H., Kasahara, K., Satouchi, M., Han, S. R., Noguchi, K., Shimamoto, T., & Kato, T. (2019). kEYNOTE‐025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1–positive advanced non–small‐cell lung cancer. Cancer science, 110(3), 1012–1020. http://access.bl.uk/ark:/81055/vdc_100077994581.0x00002e